Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenomics and breast cancer.

Pharmacogenomics - 1 Jan 2004

Lymberis Stella C, Parhar Preeti K, Katsoulakis Evangelia, Formenti Silvia C

Abstract excerpt

Germline variants can be used to study breast cancer susceptibility as well as the variable response to both drug and radiation therapy used in the treatment of breast cancer. In addition to germline high-penetrance mutations important in familial and hereditary breast cancer, a substantial component of breast cancer risk can be attributed to the combined effect of many low-risk germline polymorphisms involved in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Drug Resistance, Neoplasm
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasm Proteins

Share to Pharmacogenetics

Share to Polymorphism, Genetic

Source

Identifiers

PMID: 14683419
DOI: 10.1517/phgs.5.1.31.25686

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenomics and breast cancer.PMID 14683419Read ↗

Pharmacogenomics in breast cancer: current trends and future directions.Semantic proximity Read ↗

Genomics and pharmacogenomics of breast cancer: current knowledge and trends.Semantic proximity Read ↗

The effect of genetic variability on drug response in conventional breast cancer treatment.Semantic proximity Read ↗

Pharmacogenomics of breast cancer therapy: An updateSemantic proximity Read ↗

Pharmacogenetics of Chemotherapy Efficacy in Breast CancerSemantic proximity Read ↗

Toxicity and Pharmacogenomic Biomarkers in Breast Cancer ChemotherapySemantic proximity Read ↗

Host Factors and Risk of Breast Cancer Recurrence: Genetic, Epigenetic and Biologic Factors and Breast Cancer Outcomes.Semantic proximity Read ↗

Pharmacogenetic Predictors of Response.Semantic proximity Read ↗

The Role of Pharmacogenetic-Based Pharmacokinetic Analysis in Precise Breast Cancer TreatmentSemantic proximity Read ↗

Pharmacogenetics and pharmacogenomics of anticancer agents.Semantic proximity Read ↗

Cancer pharmacogenomics, challenges in implementation, and patient-focused perspectivesSemantic proximity Read ↗

Pharmacogenetics of breast cancer: toward the individualization of therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.